Quest for the right Drug
קלוניריט CLONNIRIT (CLONIDINE HYDROCHLORIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
טבליה : TABLETS
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects Most adverse effects are mild and tend to diminish with continued therapy. Adverse events have been ranked under headings of frequency using the following convention: very common (≥ 1/10), common (≥ 1/100, < 1/10), uncommon (≥ 1/1,000, < 1/100), rare (≥1/10,000, < 1/1,000), very rare (< 1/10,000) and unknown (cannot be calculated from the available data). Cardiac disorders: Bradyarrhythmia: not known sinus bradycardia:uncommon AV-block: rare Nervous system disorders: Dizziness, Sedation: very common Headache: common Paraesthesia: uncommon Eye disorders: Lacrimation decreased: rare. Accommodation disorder: not known Respiratory, thoracic and mediastinal disorders: Nasal dryness: rare Gastrointestinal disorders: Dry mouth: very common Constipation, Nausea, Salivary gland pain, Vomiting: common Colonic pseudo-obstruction: rare Skin and subcutaneous tissue disorders: Pruritus, Rash, Urticaria: uncommon Alopecia: rare Vascular disorders: Orthostatic hypotension: very common Raynaud's phenomenon: uncommon General disorders and administration site conditions: Fatigue: common Malaise: uncommon Reproductive system and breast disorders: Erectile dysfunction: common Endocrine disorders: Gynaecomastia: rare Psychiatric disorders: Sleep disorder, depression: common Hallucination, delusional perception, nightmare: uncommon Confusional state, libido decreased: not known Investigations: Blood glucose increased: rare Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit / risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form: https://sideeffects.health.gov.il/
שימוש לפי פנקס קופ''ח כללית 1994
Prophylaxis of migraine, menopausal flushing
תאריך הכללה מקורי בסל
01/01/1995
הגבלות
תרופה שאושרה לשימוש כללי בקופ'ח
מידע נוסף